Netherlands Heart Journal

29th Congress of the European Society of Cardiology

Hot line 1

J. P. Ottervanger

Hot line II

H. M. Nathoe

Hot line III

A. J. Teske, J. S. S. G. de Jong

Clinical trial update I

P. G. Postema

Clinical trial update II

E. E. van der Wall

Past, present and future of ACE inhibitors

S. G. Molhoek

The bridge to achieving the greater LDL-C goal of <70 mg/dl: inhibiting cholesterol absorption and production

A. H. E. M. Maas

The future of interventional therapy in cardiology

L. F. Tops

Echocardiography: a new window for the heart

N. Marsan Ajmone

If inhibition: the new strategy in cardiovascular risk management

I. R. Henkens

Setting the standard in pulmonary hypertension management

S. G. Molhoek, H. W. Vliegen

New evidence in the management of cardiovascular risk: the place of heart rate

D. A. Pijnappels

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

M. V. Huisman

Innovative device technologies for optimised heart failure management

J. A. Kragten

Highlight session

C. Ypenburg